Proteomics

Dataset Information

0

MicroRNA137-loaded lipid nanoparticles regulate synaptic proteins in the prefrontal cortex


ABSTRACT: Genome-wide association studies indicate allele variants in MIR137, the host gene of microRNA-137 (miR137), confer an increased risk of schizophrenia (SCZ). Expression of miR137 and its targets, many of which regulate synaptic functioning, are also associated with an increased risk of SCZ. As a result, miR137 represents an attractive target aimed at correcting the molecular basis for synaptic dysfunction in individuals with high genetic risk for SCZ. Advancements in nanotechnology utilize lipid nanoparticles (LNPs) to transport and deliver therapeutic RNA. However, there remains a gap in using LNPs to regulate gene and protein expression in the brain. To study the delivery of nucleic acids by LNPs to the brain, we found that LNPs released miR137 cargo and inhibited synaptic target transcripts in neuronal cultures. Biodistribution of LNPs loaded with firefly luciferase mRNA remained localized to the mouse prefrontal cortex (PFC) injection site without circulating to off-target organs. LNPs encapsulating Cre mRNA preferentially co-expressed in neuronal over microglial or astrocytic cells. Using quantitative proteomics, we found miR137 modulated glutamatergic synaptic protein networks that are commonly dysregulated in SCZ. These studies support engineering the next generation of brain-specific LNPs to deliver personalized RNA therapeutics and improve symptoms of central nervous system disorders.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Brain

SUBMITTER: Phillip Wilmarth  

LAB HEAD: Aaron Janowsky, Ph.D.

PROVIDER: PXD041648 | Pride | 2023-09-05

REPOSITORIES: Pride

altmetric image

Publications

MicroRNA137-loaded lipid nanoparticles regulate synaptic proteins in the prefrontal cortex.

Palumbo Michelle C MC   Gautam Milan M   Sonneborn Alex A   Kim Kilsun K   Wilmarth Phillip A PA   Reddy Ashok P AP   Shi Xiao X   Marks Daniel L DL   Sahay Gaurav G   Abbas Atheir I AI   Janowsky Aaron A  

Molecular therapy : the journal of the American Society of Gene Therapy 20230828 10


Genome-wide association studies indicate that allele variants in MIR137, the host gene of microRNA137 (miR137), confer an increased risk of schizophrenia (SCZ). Aberrant expression of miR137 and its targets, many of which regulate synaptic functioning, are also associated with an increased risk of SCZ. Thus, miR137 represents an attractive target aimed at correcting the molecular basis for synaptic dysfunction in individuals with high genetic risk for SCZ. Advancements in nanotechnology utilize  ...[more]

Similar Datasets

2022-02-17 | PXD026764 | Pride
2023-10-24 | PXD043519 | Pride
2020-11-20 | PXD017167 | Pride
2021-12-08 | PXD026903 | Pride
2022-04-13 | PXD013952 | Pride
2020-08-17 | PXD019032 | Pride
2023-10-09 | PXD036222 | Pride
2019-07-15 | PXD012906 | Pride
2020-08-17 | PXD019031 | Pride
2008-06-14 | E-GEOD-6509 | biostudies-arrayexpress